Karla Slowing

An effective novel delivery strategy of rasagiline for Parkinson's disease.

E. Barcia, K. Slowing, A. Fernández-Carballido, 2011, International journal of pharmaceutics.

Nanotechnology-based drug delivery of ropinirole for Parkinson’s disease

E. Barcia, L. Boeva, L. García-García, 2017, Drug delivery.

PET Imaging and Neurohistochemistry Reveal that Curcumin Attenuates Brain Hypometabolism and Hippocampal Damage Induced by Status Epilepticus in Rats

M. A. Pozo, L. García-García, K. Slowing, 2022, Planta Medica.

New celecoxib multiparticulate systems to improve glioblastoma treatment.

E. Barcia, L. García-García, K. Slowing, 2014, International journal of pharmaceutics.

Cannabidiol Enhances the Passage of Lipid Nanocapsules across the Blood-Brain Barrier Both in Vitro and in Vivo.

I. Romero, D. Male, L. García-García, 2019, Molecular pharmaceutics.

Micro- and Nano-Systems Developed for Tolcapone in Parkinson’s Disease

Mahdieh Rahmani, E. Barcia, L. García-García, 2022, Pharmaceutics.